- Home
- EVMN vs TBLD Comparison
EVMN vs TBLD Comparison
Compare EVMN & TBLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVMN | TBLD |
|---|---|---|
| Founded | 2020 | 2021 |
| Country | United States | United States |
| Employees | 48 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 825.5M | 702.5M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | EVMN | TBLD |
|---|---|---|
| Price | $22.10 | $22.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $43.88 | N/A |
| AVG Volume (30 Days) | ★ 308.6K | 67.6K |
| Earning Date | 06-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.89 | $18.25 |
| 52 Week High | $33.20 | $23.02 |
Technical Indicators
Market Signals| Indicator | EVMN | TBLD |
|---|---|---|
| Relative Strength Index (RSI) | 41.98 | 59.64 |
| Support Level | $21.39 | $19.66 |
| Resistance Level | $23.08 | $22.38 |
| Average True Range (ATR) | 1.42 | 0.35 |
| MACD | -0.21 | 0.01 |
| Stochastic Oscillator | 25.45 | 87.22 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About TBLD Thornburg Income Builder Opportunities Trust
Thornburg Income Builder Opportunities Trust is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income. The Trust will seek to achieve its investment objective by investing, directly or indirectly, at least 80% of its Managed Assets.